Clinical Trial Monitors (CRA) - UICEC
Ref.: 24-054_SS_PH
About the unit
The Clinical Research and Clinical Trials Unit (UICEC) is a platform within IDIBELL that provides support to clinical research groups conducting non-commercial clinical studies. The activities of UICEC align with the responsibilities of researchers as promoters of clinical trials (CT).
UICEC is integrated into SCREN, an ISCIII Clinical Research Support Platform (PT20/00008 and PT23 00061).
About the role
Clinical trial monitoring involves ensuring compliance with Good Clinical Practice (GCP) and research protocol requirements. Additionally, it entails collaborating with other activities related to clinical trial documentation, archiving, and follow-up.
Job requirements
Professional experience
Education and training
-
Bachelor's degree in Health Sciences (Medicine, Pharmacy, Biology, Biotechnology)
-
Training in CT Monitoring and Successful Completion of Practical Course
Technical & soft skills
Languages
We will value, but not required
- Proficiency in National Health System Protocols and Procedures
- Extensive Professional Experience and Academic Training on a Global Scale
- Advanced Proficiency in English Language
- Effective Communication Skills and Team Collaboration
- High Level of Motivation, Initiative, and Aptitude for Learning
What do we offer
-
-
Estimated start date: June 2024
-
Contract duration: Permanent linked to projects
-
Estimated annual gross salary: 26.000€ - 28.000 €
-
You will be part of a multicultural team. We have a fun loving and friendly international work environment.
-
Flexible working schedule - We know you have a life outside of work and we will work with you to make sure it's kept that way.
-
Possibility to work some days in remote - Teleworking
-
26 working days of holiday per year
-
System of accumulated hours for employees, from 88 to 104 hours depending on the year (11 to 13 working days), to attend to personal matters.
-
-
Benefits of constant training are offered
-
We offer and promote diverse and inclusive conditions. Applicants are made free from any discrimination. Specifically IDIBELL works to improve gender equality in all areas with the aim of achieving gender balance, but maintaining the most scrupulous respect to any choice at the level of gender identity. Please express yourself freely, safely and non-binarily, if that's the case.
Deadline: Please submit your application by 28/05/2024
Data protection notice
In compliance with the obligations established in the General Regulation of Data Protection (RGPD), which is the Regulation (EU) 2016/679 of the Parliament and of the Council, of April 27, 2016, and the Organic Law 3/2018, of December 5, Protection of Personal Data and guarantee of digital rights, it is reported that the Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), CIF G58863317, with address Av. Granvia de l'Hospitalet, 199-203, 08908, L'Hospitalet de Llobregat, will process your personal data, as the controller, to apply for the position, maintain communication concerning the status of the candidature, to access the delivered CV; to compare that your data is in accordance with the offers announced by IDIBELL and to verify, where appropriate, that the information provided is accurate.
You can find more information in our Privacy Policy at https://idibell.cat/en/privacy-policy-2/, request more information about the data processing carried out and exercise your rights of access, rectification, deletion, opposition, portability, limitation of processing by sending a request at email: dataprotection@idibell.cat. If you consider that you have not obtained satisfaction in exercising your rights, you may submit a claim to Catalan Data Protection Authority.
Our institute
IDIBELL is a research center that integrates the biomedical research of the Bellvitge University Hospital (HUB), the Catalan Institute of Oncology (ICO), and the University of Barcelona in the Bellvitge Campus (UB), and the Viladecans Hospital (HV). The research focuses of IDIBELL are cancer, neuroscience, translational medicine and regenerative medicine. Research, innovation and society are the pivots on which researchers work every day in order to improve the quality of life of citizens.
Observations
The 'HR Excellence in Research' award represents IDIBELL’s commitment to the implementation of Human Resources policies, which oversee the attracting and development of talent in an open, transparent, and based on personal merit, in alignment with the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment Researchers (Charter and Code).
IDIBELL is committed to the principles of the Code of Conduct for the Recruitment of Researchers of the European Commission and the implementation of open, transparent and merit-based recruitment (OTMR).
This contract is co-financed by Instituto de Salud Carlos III, with the file code PT20/0008, pursuant to the Resolution of the Directorate of Instituto de Salud Carlos III, O.A., M.P., dated December 11, 2020, grants for the Units of the ISCIII Platforms to support R&D&I in Biomedicine and Health Sciences of the Strategic Action in Health 2017-2020, and by the European Social Fund (2014-2020 Programming Period) "The ESF invests in your future".
